查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405911

花生過敏治療市場規模、佔有率、趨勢分析報告：按藥物類別、給藥途徑、配銷通路管道、地區和細分市場預測，2024-2030 年

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

花生過敏治療市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球花生過敏治療市場規模預計將達到 10.1 億美元。

預計2024年至2030年該市場將以11.82%的複合年成長率成長。推動市場成長的關鍵因素包括強大的產品平臺、高疾病盛行率、藥物輸送系統的進步以及主要企業的策略性舉措。

市場主要企業正在透過各種策略加強其花生過敏治療管道。例如，Aravax 於 2022 年 12 月啟動了 B 輪資金籌措，獲得了澳洲著名醫療保健企業家 Tenmile 和 Brandon Capital 的 2,000 萬美元投資。這筆資金籌措將使 Aravax 能夠在對花生過敏的人群中開始 PVX108 的 II 期臨床試驗。此類資金籌措預計將推進研究和開發計劃。

花生過敏藥物核准數量的增加也刺激了市場。 2020年1月，美國食品藥物管理局（FDA）批准了由Aimmune Therapeutics, Inc.開發的PALFORZIA [花生（花生）過敏原粉-dnfp]。 PALFORZIA 是第一個核准用於花生過敏患者的免疫療法。該藥物是一種口服免疫治療劑，旨在減輕因意外攝入花生而引起的過敏反應，包括過敏反應。該藥適用於已確診過敏的患者，建議 4 至 17 歲兒童增加初始給藥。

截至 2023 年第一季，幾種有前途的研發線產品正在臨床開發中。其中包括 DBV Technologies 的 Viaskin Peanut、Dupixient 的 CA002 以及賽諾菲 (Sanofi) 和 Regeneron 的合作產品 Camallegr。此外，ADP101、VE416、INP20 和 CNP-201 等資產正在開發中。預計這些藥物的推出將有助於預測期內的市場成長和擴張。

花生過敏治療市場報告亮點

  • 2023 年，腎上腺素細分市場佔據主要市場佔有率。過敏反應的標準治療方法是腎上腺素自動注射器，這對於緊急過敏管理也至關重要。
  • 從給藥途徑來看，注射劑在 2023 年佔據市場主導地位。這是由於人們越來越重視以患者為中心的護理，以及實用、痛苦較小且更易於患者使用的注射劑市場的開拓。這包括考慮注射療法的替代輸送系統，例如穿戴式技術和自動注射器。
  • 按配銷通路，2023年醫院藥房細分市場佔據最大市場佔有率。醫院藥房致力於為花生過敏患者提供支持和資訊。
  • 北美在這個市場上擁有強大的區域地位。這是因為目前有許多製藥公司、學術機構和研究機構正在研究解決花生過敏根本原因的新治療策略，包括生技藥品療法、生物製劑和其他免疫調節干預措施。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢及展望
  • 市場動態
    • 花生過敏治療藥物核准增加
    • 花生過敏盛行率增加
    • 醫療費用增加
  • 市場抑制因素分析
    • 處理成本和產品成本高
  • 營商環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
  • COVID-19感染疾病的影響分析

第4章給藥途徑業務分析

  • 花生過敏治療市場：給藥途徑變化分析
  • 口服
  • 可注射的
  • 其他

第5章醫藥類業務分析

  • 花生過敏治療市場：藥物類別變異分析
  • 抗組織胺藥
  • 腎上腺素
  • 免疫療法
  • 其他

第6章配銷通路業務分析

  • 花生過敏治療市場：配銷通路波動分析
  • 醫院藥房
  • 零售藥房
  • 其他

第7章 區域業務分析

  • 2023 年及 2030 年花生過敏治療市場佔有率（按地區）
  • 北美洲
    • SWOT分析
    • 北美花生過敏治療市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 歐洲花生過敏治療市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 亞太地區花生過敏治療市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲花生過敏治療市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • SWOT分析
    • MEA 花生過敏治療市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 參與企業概況
  • 財務績效
  • 參與企業
    • 市場領導者
    • 2023 年花生過敏治療市場佔有率佔分析
    • 公司簡介
    • 策略規劃
Product Code: GVR-4-68040-097-6

Peanut Allergy Treatment Market Growth & Trends:

The global peanut allergy treatment market size is expected to reach USD 1.01 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 11.82% from 2024 to 2030. Some of the key factors propelling the market growth include a robust product pipeline, high disease prevalence, advancement in the drug delivery system, and strategic initiatives by key players.

Key market players are bolstering their pipeline for peanut allergy treatment through various strategies. For instance, Aravax initiated its series B funding round in December 2022, securing a USD 20 million investment from renowned Australian healthcare entrepreneurs Tenmile and Brandon Capital. This financing will enable Aravax to commence phase II clinical trials of PVX108, targeting individuals who experience allergic reactions to peanuts. Such fundings are expected to drive advancements in research and development programs.

The market is stimulated by the increasing number of product approvals for peanut allergy treatment. In January 2020, the U.S. Food and Drug Administration (FDA) granted authorization to PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp], developed by Aimmune Therapeutics, Inc. PALFORZIA is the first immunotherapy medication approved for individuals with peanut allergies. It is an oral immune therapy designed to reduce allergy responses, including anaphylaxis triggered by accidental peanut ingestion. It is intended for individuals who have a confirmed allergy, with initial dose escalation recommended for children aged four to 17.

As of the first quarter of 2023, several promising pipeline products are undergoing clinical development. These include Viaskin Peanut by DBV Technologies, CA002 by Dupixient, and Camallegr, a collaborative effort between Sanofi and Regeneron. Additionally, other assets such as ADP101, VE416, INP20, and CNP-201 are also in development. The introduction of these medications is anticipated to contribute to the growth and expansion of the market during the projected forecast period.

Peanut Allergy Treatment Market Report Highlights:

  • The epinephrine segment held the major market share in 2023. The standard of care for anaphylaxis treatment has been epinephrine auto-injectors, which are also essential in the management of allergies in emergency situations
  • By route of administration, the injectable segment dominated the market in 2023 owing to the development of injectable treatments that are practical, less painful, and easier to use for patients is being pursued in response to the growing emphasis on patient-centered care. This includes looking at alternative delivery systems for injectable therapies, such as wearable technology or auto-injectors
  • By distribution channel, the hospital pharmacy segment held the largest market share in 2023. Hospital pharmacies put more of an emphasis on offering patient support and information for people with peanut allergies
  • North America has established a strong regional position in the market. This is due to the presence of numerous pharmaceutical companies, academic institutions, and research organizations currently looking into new therapeutic strategies to address the underlying causes of peanut allergies, including gene therapy, biologics, and other immunomodulatory interventions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Drug Class and Route of Administration Snapshot
  • 2.3. Distribution Channel Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising product approvals for the treatment of peanut allergy
    • 3.4.2. Increasing prevalence of peanut allergies
    • 3.4.3. Increasing healthcare expenditure
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of the treatment and the products
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Route Of Administration Business Analysis

  • 4.1. Peanut Allergy Treatment Market: Route Of Administration Movement Analysis
  • 4.2. Oral
    • 4.2.1. Oral Market, 2018 - 2030 (USD Million)
  • 4.3. Injectable
    • 4.3.1. Injectable Market, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Drug Class Business Analysis

  • 5.1. Peanut Allergy Treatment Market: Drug Class Movement Analysis
  • 5.2. Antihistamines
    • 5.2.1. Antihistamines Market, 2018 - 2030 (USD Million)
  • 5.3. Epinephrine
    • 5.3.1. Epinephrine Market, 2018 - 2030 (USD Million)
  • 5.4. Immunotherapies
    • 5.4.1. Immunotherapies Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Distribution Channel Business Analysis

  • 6.1. Peanut Allergy Treatment Market: Distribution Channel Movement Analysis
  • 6.2. Hospital Pharmacy
    • 6.2.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Peanut Allergy Treatment Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Peanut Allergy Treatment Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. U.S. Peanut Allergy Treatment market, 2018 - 2030 (USD MILLION)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Canada Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. Germany Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. UK Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. France Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Italy Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Spain Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Denmark Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Sweden Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Reimbursement Scenario
      • 7.3.10.6. Norway Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. Japan Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. China Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. India Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. South Korea Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Australia Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.8. Thailand
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Reimbursement Scenario
      • 7.4.8.6. Thailand Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Brazil Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Mexico Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Reimbursement Scenario
      • 7.5.5.6. Argentina Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. South Africa Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. Saudi Arabia Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. UAE Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Reimbursement Scenario
      • 7.6.6.6. Kuwait Peanut Allergy Treatment market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant's overview
  • 8.2. Financial performance
  • 8.3. Participant categorization
    • 8.3.1. Market Leaders
    • 8.3.2. Peanut Allergy Treatment market Share Analysis, 2023
    • 8.3.3. Company Profiles
      • 8.3.3.1. Sanofi
      • 8.3.3.1.1. Company Overview
      • 8.3.3.1.2. Financial Performance
      • 8.3.3.1.3. Product Benchmarking
      • 8.3.3.1.4. Strategic Initiatives
      • 8.3.3.2. Aimmune Therapeutics Inc.
      • 8.3.3.2.1. Company Overview
      • 8.3.3.2.2. Financial Performance
      • 8.3.3.2.3. Product Benchmarking
      • 8.3.3.2.4. Strategic Initiatives
      • 8.3.3.3. DBV Technologies
      • 8.3.3.3.1. Company Overview
      • 8.3.3.3.2. Financial Performance
      • 8.3.3.3.3. Product Benchmarking
      • 8.3.3.3.4. Strategic Initiatives
      • 8.3.3.4. Vedanta Biosciences, Inc.
      • 8.3.3.4.1. Company Overview
      • 8.3.3.4.2. Financial Performance
      • 8.3.3.4.3. Product Benchmarking
      • 8.3.3.4.4. Strategic Initiatives
      • 8.3.3.5. Alladapt Immunotherapeutics, Inc.
      • 8.3.3.5.1. Company Overview
      • 8.3.3.5.2. Financial Performance
      • 8.3.3.5.3. Product Benchmarking
      • 8.3.3.5.4. Strategic Initiatives
      • 8.3.3.6. Regeneron Pharmaceuticals Inc.
      • 8.3.3.6.1. Company Overview
      • 8.3.3.6.2. Financial Performance
      • 8.3.3.6.3. Product Benchmarking
      • 8.3.3.6.4. Strategic Initiatives
      • 8.3.3.7. Aravax Pty Ltd
      • 8.3.3.7.1. Company Overview
      • 8.3.3.7.2. Financial Performance
      • 8.3.3.7.3. Product Benchmarking
      • 8.3.3.7.4. Strategic Initiatives
      • 8.3.3.8. Prota Therapeutics
      • 8.3.3.8.1. Company Overview
      • 8.3.3.8.2. Financial Performance
      • 8.3.3.8.3. Product Benchmarking
      • 8.3.3.8.4. Strategic Initiatives
      • 8.3.3.9. Teva Pharmaceuticals Industries Ltd.
      • 8.3.3.9.1. Company Overview
      • 8.3.3.9.2. Financial Performance
      • 8.3.3.9.3. Product Benchmarking
      • 8.3.3.9.4. Strategic Initiatives
    • 8.3.4. Strategy Mapping
      • 8.3.4.1. Expansion
      • 8.3.4.2. Acquisition
      • 8.3.4.3. Collaborations
      • 8.3.4.4. Route Of Administration/Drug Class Launch
      • 8.3.4.5. Partnerships
      • 8.3.4.6. Others

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 3 Global Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 4 Global Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 5 Global Peanut Allergy Treatment Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 8 North America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 9 North America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 11 U.S. Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 12 U.S. Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 14 Canada Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 15 Canada Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Europe Peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 18 Europe peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 19 Europe peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Germany Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 21 Germany Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 22 Germany Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 UK Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 24 UK Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 25 UK Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 France Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 27 France Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 28 France Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 Italy Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 30 Italy Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 31 Italy Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Spain Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 33 Spain Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 34 Spain Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Denmark Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 36 Denmark Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Denmark Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Sweden Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 39 Sweden Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 40 Sweden Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Norway Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 42 Norway Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 43 Norway Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 China Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 49 China Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 50 China Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 Japan Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 52 Japan Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Japan Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 India Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 55 India Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 56 India Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 South Korea Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 58 South Korea Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 59 South Korea Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 Australia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 61 Australia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Australia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Thailand Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 64 Thailand Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 65 Thailand Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Latin America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 67 Latin America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 68 Latin America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 69 Latin America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Brazil Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 71 Brazil Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 72 Brazil Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Mexico Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 74 Mexico Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 75 Mexico Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 77 Argentina Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 78 Argentina Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 83 South Africa Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 84 South Africa Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 85 South Africa Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 UAE Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 90 UAE Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 91 UAE Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Peanut allergy treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Route of administration and distribution channel segment snapshot
  • Fig. 11 Drug class segment snapshot
  • Fig. 12 Competitive landscape snapshot
  • Fig. 13 Allergy diagnostics and therapeutics market value, 2023 (USD billion)
  • Fig. 14 Market dynamics
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 PESTLE analysis
  • Fig. 17 KOLs perspective
  • Fig. 18 KOLs perspective
  • Fig. 19 KOLs perspective
  • Fig. 20 Peanut allergy treatment market: Route of administration outlook and key takeaways
  • Fig. 21 Peanut allergy treatment market: Route of administration movement analysis
  • Fig. 22 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Peanut allergy treatment market: Drug class outlook and key takeaways
  • Fig. 26 Peanut allergy treatment market: Drug class movement analysis
  • Fig. 27 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Epinephrine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Immunotherapies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Peanut allergy treatment market: Distribution channel outlook and key takeaways
  • Fig. 32 Peanut allergy treatment market: Distribution channel movement analysis
  • Fig. 33 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Peanut allergy treatment market revenue, by region, 2023 & 2030 (USD Million)2023 & 2030 (USD Million)2023 & 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 North America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 U.S. peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. healthcare system: Money flow
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Drug pricing
  • Fig. 65 Asia Pacific peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Japan pharmaceutical registration
  • Fig. 69 Key country dynamics
  • Fig. 70 China peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Regulatory details: China
  • Fig. 72 Exclusivity formula
  • Fig. 73 Key country dynamics
  • Fig. 74 India peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Registration details: India
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Drug pricing: Australia
  • Fig. 79 Contribution of PBS by disease
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Korea peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Reimbursement scenario: South Korea
  • Fig. 85 Rest of Asia Pacific peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Mexico peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Regulatory framework
  • Fig. 92 Reimbursement scenario
  • Fig. 93 Key country dynamics
  • Fig. 94 Argentina peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Argentina pharmaceuticals registration details
  • Fig. 96 Argentina pharmaceuticals reimbursement details
  • Fig. 97 Rest of Latin America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Middle East and Africa peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 South Africa peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Regulatory framework: South Africa
  • Fig. 102 Regulatory framework: South Africa drug registration fees
  • Fig. 103 Key country dynamics
  • Fig. 104 Saudi Arabia peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UAE peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Kuwait peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Regulatory framework: South Africa
  • Fig. 110 Rest of MEA peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)